Get started
Author

Nina Paulshus Sundlisæter

Observed names: N. Sundlisæter, N.P. Sundlisæter, NP Sundlisater, Nina Paulshus Sundlisater, Nina Sundlisater, nina sundlisater
ORCID: 0000-0002-1295-0172
Observed ORCID: 0000-0002-1295-0172
OpenAlex ID: A5079682019
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis
2017 · Maria Karolina Jonsson, Nina Paulshus Sundlisæter, et al. · Annals of the Rheumatic Diseases · 63
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes
2018 · Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al. · Annals of the Rheumatic Diseases · 33
PDF
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission
2021 · Siri Lillegraven, Nina Paulshus Sundlisæter, et al. · JAMA · 31
PDF
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy
2021 · Ulf Sundin, Nina Paulshus Sundlisater, et al. · RMD Open · 29
PDF
Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol
2018 · Nina Paulshus Sundlisæter, Inge C Olsen, et al. · Lara D. Veeken · 26
PDF
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
2023 · Siri Lillegraven, Nina Paulshus Sundlisæter, et al. · Annals of the Rheumatic Diseases · 25
PDF
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment
2021 · Karen Holten, Nina Paulshus Sundlisater, et al. · Annals of the Rheumatic Diseases · 25
PDF
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
2024 · Kaja E Kjørholt, Nina Paulshus Sundlisæter, et al. · The Lancet Rheumatology · 17
PDF
Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis
2022 · Shrikant S. Kolan, Gaoyang Li, et al. · Frontiers in Pharmacology · 11
PDF
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
2022 · Nina Paulshus Sundlisæter, Ulf Sundin, et al. · RMD Open · 8
PDF
Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control
2023 · Siri Lillegraven, Nina Paulshus Sundlisæter, et al. · JAMA · 7
Three‐Year Results of Tapering Tumor Necrosis Factor Inhibitor to Withdrawal Compared to Stable Tumor Necrosis Factor Inhibitor Among Patients With Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial
2025 · Kaja E. Kjørholt, Nina Paulshus Sundlisæter, et al. · Arthritis & Rheumatology · 6
PDF
Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study
2025 · Gaoyang Li, Shrikant S. Kolan, et al. · Frontiers in Medicine · 5
PDF
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity
2024 · Karen Holten, Nina Paulshus Sundlisæter, et al. · RMD Open · 5
PDF
Sat0113 Limiting Factors of Reaching Acr/eular Boolean Remission in Early Ra Patients Treated According to Current Guidelines
2019 · Nina Sundlisater, Anna-Birgitte Aga, et al. · Annals of the Rheumatic Diseases · 4
PDF
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials
2024 · Karen Holten, Nina Paulshus Sundlisæter, et al. · RMD Open · 3
PDF
Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study
2023 · Valeriia Melokhina, Nina Paulshus Sundlisæter, et al. · Annals of the Rheumatic Diseases · 3
PDF
Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis
2021 · Nina Paulshus Sundlisater, Anna-Birgitte Aga, et al. · Annals of the Rheumatic Diseases · 3
Op0019 Stable Versus Tapered and Withdrawn Treatment With Tumor Necrosis Factor Inhibitor in Rheumatoid Arthritis Remission (arctic Rewind): a Randomised, Open-label, Phase 4, Non-inferiority Trial
2020 · S. Lillegraven, N.P. Sundlisæter, et al. · Annals of the Rheumatic Diseases · 2
PDF
Fri0622 Joint Tenderness and Ultrasound Inflammation in Early Rheumatoid Arthritis Patients Included in the Arctic Trial
2019 · nina sundlisater, Anna-Birgitte Aga, et al. · Annals of the Rheumatic Diseases · 2
PDF
Response to: ‘Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis’ by Chevreau et al
2018 · Maria Karolina Jonsson, Nina Paulshus Sundlisæter, et al. · Annals of the Rheumatic Diseases · 2
PDF
FRI0121 Remission at 6 months and identification of future good radiographic and physical outcome in early rheumatoid arthritis
2017 · NP Sundlisater, A-B Aga, et al. · Annals of the Rheumatic Diseases · 2
PDF
Op0279-hpr Responsiveness and Discriminative Ability of the Rheumatoid Arthritis Impact of Disease (raid) Score to Clinical Disease Flare: Data From the Dmard Tapering Arctic Rewind Trials
2023 · K. Holten, N.P. Sundlisæter, et al. · Annals of the Rheumatic Diseases · 1
PDF
Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis—Reply
2021 · Siri Lillegraven, Nina Paulshus Sundlisæter, et al. · JAMA · 1
Remission in early rheumatoid arthritis: Predictors, definitions and treatment
2020 · Nina Paulshus Sundlisæter · NORA - Norwegian Open Research Archives · 1
Works count: 36
Citation count: 315
H-index: 9
I10-index: 9
Year
Topic
Type